{
  "pmid": "24352253",
  "uid": "24352253",
  "title": "A case of refractory SÃ©zary syndrome with large-cell transformation responsive to brentuximab vedotin.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Corey",
      "fore_name": "Kristen",
      "initials": "K",
      "name": "Kristen Corey",
      "affiliations": [
        "University of Massachusetts Medical School, Worcester."
      ]
    },
    {
      "last_name": "Cook",
      "fore_name": "Deborah",
      "initials": "D",
      "name": "Deborah Cook",
      "affiliations": [
        "Department of Pathology, University of Vermont College of Medicine, Burlington."
      ]
    },
    {
      "last_name": "Bekker",
      "fore_name": "Jessica",
      "initials": "J",
      "name": "Jessica Bekker",
      "affiliations": [
        "Department of Pathology, University of Vermont College of Medicine, Burlington."
      ]
    },
    {
      "last_name": "Mugnaini",
      "fore_name": "Emiliano",
      "initials": "E",
      "name": "Emiliano Mugnaini",
      "affiliations": [
        "Division of Hematology/Oncology, University of Vermont College of Medicine, Burlington."
      ]
    },
    {
      "last_name": "Lin",
      "fore_name": "Julie H",
      "initials": "JH",
      "name": "Julie H Lin",
      "affiliations": [
        "Division of Dermatology, University of Vermont College of Medicine, Burlington."
      ]
    }
  ],
  "journal": {
    "title": "JAMA dermatology",
    "iso_abbreviation": "JAMA Dermatol",
    "issn": "2168-6084",
    "issn_type": "Electronic",
    "volume": "150",
    "issue": "2",
    "pub_year": "2014",
    "pub_month": "Feb"
  },
  "start_page": "210",
  "end_page": "212",
  "pages": "210-2",
  "language": "eng",
  "publication_types": [
    "Case Reports",
    "Journal Article"
  ],
  "keywords": [
    "Aged, 80 and over",
    "Antineoplastic Agents",
    "Brentuximab Vedotin",
    "Cell Transformation, Neoplastic",
    "Female",
    "Humans",
    "Immunoconjugates",
    "Lymphoma, Large-Cell, Anaplastic",
    "Sezary Syndrome",
    "Skin Neoplasms",
    "Treatment Outcome"
  ],
  "article_ids": {
    "pubmed": "24352253",
    "doi": "10.1001/jamadermatol.2013.5741",
    "pii": "1790349"
  },
  "doi": "10.1001/jamadermatol.2013.5741",
  "dates": {
    "completed": "2014-04-15",
    "revised": "2019-12-10"
  },
  "chemicals": [
    "Antineoplastic Agents",
    "Immunoconjugates",
    "Brentuximab Vedotin"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:15:21.114236",
    "pmid": "24352253"
  }
}